http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100709289-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2200-308 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2200-324 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-716 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L29-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-062 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-716 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate | 2005-09-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2007-04-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2007-04-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-100709289-B1 |
| titleOfInvention | Pharmaceutical composition for enhancing cancer and immune function including β-glucan |
| abstract | The present invention relates to a pharmaceutical composition and a health functional food comprising β-glucan as an active ingredient, and more particularly, to a glucose main chain connected by β-1,3 bond, wherein at least one of the glucose is branched glucose and It relates to a pharmaceutical composition and health functional food comprising a water-soluble β-1,3 / 1,6-glucan or derivatives thereof, which are gentiobiose linked by β-1,6 bonds, as an active ingredient.n n n The β-1,3 / 1,6-glucan has excellent anticancer and immune function enhancing effects and can be usefully used as a prophylactic and therapeutic agent for cancer diseases and immune lowering related diseases.n n n n Anti-cancer, enhance immune function, β-glucan, aureobasidium pullulan, dietary supplement |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20170079102-A |
| priorityDate | 2005-09-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 161.